Drugs / KXV01 TCR Lentinvivo
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07275853 | Dec 2025 → Dec 2026 expected | cancer | TCRx Therapeutics Co.Ltd | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07196579 | Oct 2025 → Dec 2026 expected | cancer | TCRx Therapeutics Co.Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KXV01 TCR Lentinvivo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07196579 ↗ |